Eli Lilly and Company has achieved a historic milestone, becoming the first healthcare company in history to reach a market capitalization of $1 trillion. This remarkable achievement marks […]
Bitcoin Market Feels Ripple Effects of New Pharmaceutical Tariffs
A new round of tariffs on non-U.S. made pharmaceuticals has sparked volatility in the global market and is prompting speculation about how it might affect trade routes. The […]
Trump Negotiates Drug Price Cuts with Pharma Giants, Lowering Costs for Millions
Former President Donald Trump secured a deal that significantly reduces the cost of GLP-1 weight loss drugs like Ozempic, Wegovy, and Zepbound. This agreement will impact millions of […]
Pfizer’s Q3 Earnings Beat Expectations Despite Revenue Dip
Pfizer Inc. (PFE) exceeded analysts’ expectations for earnings per share (EPS) in the third quarter of 2025, showcasing its focus on long-term growth and efficiency despite a slight […]
Eli Lilly Shines in Q3, Raises Revenue and EPS Outlook
Eli Lilly and Company (NYSE: LLY) delivered a strong performance in its third quarter 2025 financial report, driving revenue growth driven by key products and strategic advancements in […]
Merck Surpasses Earnings Estimates, Raises Full-Year Outlook for 2025
Merck & Co., Inc. recently reported impressive third-quarter earnings exceeding expectations, driving a revised full-year outlook. The company’s strong performance was fueled by the continued success of KEYTRUDA […]
GLP-1 Drugs: A Surging Sector Exceeding Global Markets
Over the past five years, GLP-1 drugs for weight management have seen unprecedented growth, outperforming the performance of traditional pharmaceuticals and even broader markets like the S&P 500. […]
U.S.-EU Framework Agreement: A New Era for Autos and Pharma
The U.S. and EU have struck a landmark agreement, tackling trade imbalances through a new framework. The deal aims for reciprocity and fairness, with crucial details revealing the […]
EVOK Stock Soars 25% After Patent Victory
Shares of Evoke Pharma (NASDAQ: EVOK) surged by over 25%, reaching $7.31, in premarket trading on Thursday following news about a significant patent win. The pharmaceutical company’s GIMOTI […]
Trump’s Tariff Threats Trigger Volatility in Pharma Stocks
Pharmaceutical companies are facing uncertainty as Donald Trump’s tariff threats weigh heavily on their stocks. Major pharmaceutical giants like Pfizer and Eli Lilly are grappling with potential price […]
German Pharma Firm Invests in Bitcoin, Expanding Digital Asset Reserve
A prominent German pharmaceutical company has significantly expanded its holdings of Bitcoin by purchasing an additional 100 BTC in May 2025. The investment, valued at approximately €10 million […]
Hedge Funds Seek Growth in Chinese Self-Driving Taxis and Indian Pharma: Sohn Hong Kong Insights
Hedge funds at Sohn Hong Kong’s 2025 conference have identified promising investment opportunities beyond traditional sectors. The focus on geographical diversification, driven by counter-tariff uncertainties and market volatility, […]
Jiangsu Hengrui Soars with HK IPO Success, Raises $1.3 Billion
Jiangsu Hengrui’s successful initial public offering (IPO) on the Hong Kong Stock Exchange has sparked significant excitement in the market, raising over $1.3 billion and signaling strong confidence […]
Novo Nordisk Stock Plunges as CEO Steps Down amid Market Headwinds
Danish pharmaceutical giant Novo Nordisk announced that Lars Fruergaard Jørgensen, its CEO, will be stepping down amidst a difficult period marked by escalating competition in the obesity drug […]
Novo Nordisk vs Eli Lilly: Analyzing Their Potential for Market Domination in Obesity Treatment by 2025
This article analyzes the performance of Novo Nordisk (NVO) and Eli Lilly (LLY), two pharmaceutical giants, in the rapidly growing obesity market. While both companies have seen stock […]